• 0
Shop Products $

KN-93 phosphateCaM kinase II inhibitor inhibitor 1 mg. KN-93 phosphateCaM kinase II inhibitor inhibitor, Formula: C26H29ClN2O4S. H3PO4, MW: 501.0. 98.0, Cas No: 1188890-41-6, Purity: /= 98%, Appearance:White to off-white solid, Synonyms: KN-93 (water soluble), 2-[N-(2-Hydroxyethyl), Size: 1 mg

KN-93 phosphateCaM kinase II inhibitor inhibitor 5 mg. KN-93 phosphateCaM kinase II inhibitor inhibitor, Formula: C26H29ClN2O4S. H3PO4, MW: 501.0. 98.0, Cas No: 1188890-41-6, Purity: /= 98%, Appearance:White to off-white solid, Synonyms: KN-93 (water soluble), 2-[N-(2-Hydroxyethyl), Size: 5 mg

6BIO Inibitor of phosphoinositide-dependent kinase 1 and GSK inhibitor 5 mg. 6BIO Inibitor of phosphoinositide-dependent kinase 1 and GSK inhibitor, Formula: C16H10BrN3O2, phosphoinositide-dependent, Molecular Weight: 356.2, Cas No: 667463-62-9, Purity: /= 98%, Appearance:Dark red solid, Size: 5 mg

Necrostatin-7Necroptosis inhibitor inhibitor 5 mg. Necrostatin-7Necroptosis inhibitor inhibitor, Formula: C16H10N5OS2F, Molecular Weight: 371.4, Cas No: 351062-08-3, Purity: greater than or equal to 98%, Appearance:Yellow solid, Solubility: Soluble in DMSO, Storage: -20 deg C, Size: 5 mg

Mito-TEMPO-H Spin probe 5 mg. Mito-TEMPO-H Spin probe, Formula: C29H37N2O2Cl2P. H2O, MW: 511.1. 18.0, Purity: /= 95%, Synonyms: 1-hydroxy-4-[2-triphenylphosphonio)-acetamido]-2,2,6,6-tetramethylpiperidine, 1-Hydroxy-2,2,6,6-tetramethyl-4-[2-(triphenylphosphonio)acetamido, Size: 5 mg

Necrox-5. Hydrochloride Necrosis inhibitor inhibitor 1 mg. Necrox-5. Hydrochloride Necrosis inhibitor inhibitor, Formula: C25H31N3O3S. 2 HCl, MW: 453.6. 72.9, Purity: /= 96%, Appearance:Yellow solid, Synonyms: [5-(1,1-Dioxo-thiomorpholin-4-ylmethyl)-2-phenyl-1H-indol-7-yl], Size: 1 mg

Vitamin A acetate 1 g. Vitamin A acetate, Formula: C22H32O2, Molecular Weight: 328.5, Cas No: 127-47-9, Purity: /= 95%, Appearance: Off-white to pale yellow crystalline solid, Solubility: Soluble in ethanol, chloroform, and ether. Insoluble in water, Synonyms: Retinyl acetate, Size: 1 g

Vitamin A acetate 5 g. Vitamin A acetate, Formula: C22H32O2, Molecular Weight: 328.5, Cas No: 127-47-9, Purity: /= 95%, Appearance: Off-white to pale yellow crystalline solid, Solubility: Soluble in ethanol, chloroform, and ether. Insoluble in water, Synonyms: Retinyl acetate, Size: 5 g

B2-Microglobulin (human) native 100 ug. B2-Microglobulin (human) native, Molecular Weight: 12kDa, Purity: greater than or equal to 95%, Source: Rough (R)-form LPS isolated and purified from E. Coli R515, Synonyms: Lipopolysaccharide from E. Coli, Serotype R515 (Re), Storage: +4 deg C, Size: 100 ug

3-Methyladenine PI3 kinase inhibitor 25 mg. 3-Methyladenine PI3 kinase inhibitor, inhibiting starvation-induced autophagy, Formula: C6H7N5, MW: 149.2, CAS: 5142-23-4, Purity: /= 98% (HPLC), Appearance: White solid, Synonyms: 6-Amino-3-methylpurine, Storage: -20 deg C, Size: 25 mg

Timosaponin AIII mTOR inhibitor 5 mg. Timosaponin AIII mTOR inhibitor, Formula: C39H64O13, MW: 740.9, CAS: 41059-79-4, Induces autophagy in HeLa cells followed by apoptotic cell death, cellular response found to be mediated via inhibitio, Purity: /= 96% (HPLC), Appearance: White solid, Size: 5 mg

(R)-Roscovitine CDK inhibitor CDK inhibitor 2 mg. (R)-Roscovitine CDK inhibitor CDK inhibitor, Formula: C19H26N6O, MW: 354.4, Cas No: 186692-46-6, Purity: /= 95%, Appearance:White to off-white solid, Synonyms: 6-Benzylamino-2-(R)-[(1-ethyl)-2-hydroxyethylamino]-9-isopropylpurine, 2, Size: 2 mg

Dibutyryl-cAMPPKA activator 30mg. Dibutyryl-cAMPPKA activator, Formula: C18H23N5O8P. Na, Molecular Weight: 491.4, Cas No: 16980-89-5, Purity: /= 98%, Appearance: White crystalline solid, Solubility: Soluble in water (100mg/ml), Synonyms: Dibutyl cyclic AMP sodium salt, Size: 30mg

ZK-756326CCR8 activator 10 mg. ZK-756326CCR8 activator, Formula: C21H28N2O3.2HCl, Molecular Weight: 356.4.73.0, Cas No: 874911-96-3, Purity: greater than or equal to 98%, Appearance: White solid, Synonyms: 2-[2-[4-[(3-Phenoxyphenyl)methyl]-1-piperazinyl]ethoxy]ethanol dihydrochloride, Size: 10 mg

ZK-756326CCR8 activator 50 mg. ZK-756326CCR8 activator, Formula: C21H28N2O3.2HCl, Molecular Weight: 356.4.73.0, Cas No: 874911-96-3, Purity: greater than or equal to 98%, Appearance: White solid, Synonyms: 2-[2-[4-[(3-Phenoxyphenyl)methyl]-1-piperazinyl]ethoxy]ethanol dihydrochloride, Size: 50 mg

25-Hydroxyvitamin D2High purity vitamin D2 intermediate 1 mg. 25-Hydroxyvitamin D2High purity vitamin D2 intermediate, Formula: C28H44O2, Molecular Weight: 412.65, Cas No: 21343-40-8, Purity: /= 98%, Synonyms: Ercalcidiol, 25-Hydroxyergocalciferol, 25-Hydroxycalciferol, Size: 1 mg

N-(p-Amylcinnamoyl)anthranilic acid inhibitor 50 mg. N-(p-Amylcinnamoyl)anthranilic acid inhibitor, Formula: C21H23NO3, Molecular Weight: 337.4, Cas No: 110683-10-8, Purity: greater than or equal to 99%, Appearance: White solid, Synonyms: ACA, Storage: -20 deg C, Size: 50 mg

GF109203XPKC inhibitor 5 mg. GF109203XPKC inhibitor, Formula: C25H24N4O2, MW: 412.5, Cas No: 133052-90-1, Purity: greater than or equal to 98%, Appearance: Red solid, Synonyms: 2-[1-(3-Dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl)maleimide, Bisindolylmaleimide I, Size: 5 mg

ZM-323881 VEGFR inhibitor 5 mg. ZM-323881 VEGFR inhibitor, Formula: C22H18FN3O2, MW: 375.4, Cas No: 193001-14-8, Purity: greater than or equal to 98%, Appearance: White to off-white solid, Source: Synthetic, Synonyms: 5-((7-Benzyloxyquinazolin-4-yl)amino)-4-fluoro-2-methyl phenol, Size: 5 mg

BML-282UCH inhibitor inhibitor 5 mg. BML-282UCH inhibitor inhibitor, Formula: C17H11BrCl2N2O3, Molecular Weight: 442.1, Purity: greater than or equal to 98%, Appearance:Yellow solid, Synonyms: N-(3,4-Dichlorobenzyl)-5-bromoisatin O-acetyloxime, Storage: -20 deg C, Size: 5 mg

PF-622FAAH inhibitor 5 mg. PF-622FAAH inhibitor, covalently modifying the enzyme's active site, Formula: C21H22N4O, MW: 346.4, Cas No: 898235-65-9, Purity: /= 98%, Appearance: Off-white solid, Synonyms: N-phenyl-4-(quinolin-2-ylmethyl)piperazine-1-carboxamide, Storage: -20 deg C, Size: 5 mg

BML-283 Pyruvate kinase M2 activator 25 mg. BML-283 Pyruvate kinase M2 activator, Formula: C19H22N2O7S2, Molecular Weight: 454.5, Purity: /= 98%, Synonyms: NCGC00030335, 1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-ylsulfonyl)-4-(4-methoxyphenylsulfonyl)-piperazine, Storage: -20 deg C, Size: 25 mg

PAP-AMC, Tyrosinase substrate 100 ug. PAP-AMC, Tyrosinase substrate, Formula: C17H14N2O4, Molecular Weight: 310.3, Purity: greater than or equal to 98%, Appearance: Off-white solid, Synonyms: 1-(4-Methyl-coumarin-7-yl)-3-(4-hydroxyphenyl)urea, Storage: -20 deg C, Size: 100 ug

BI-D1870S6 kinase inhibitor inhibitor 1 mg. BI-D1870S6 kinase inhibitor inhibitor, Formula: C19H23F2N5O2, MW: 391.4, Cas No: 501437-28-1, Purity: /= 98%, Appearance:Off-white solid, Synonyms: (5-Difluoro-4-hydroxyphenyl)amino]-7,8-dihydro-5,7-dimethyl-8-(3-methylbutyl)-6(5H)-pteridone, Size: 1 mg

BI-D1870S6 kinase inhibitor inhibitor 5 mg. BI-D1870S6 kinase inhibitor inhibitor, Formula: C19H23F2N5O2, MW: 391.4, Cas No: 501437-28-1, Purity: /= 98%, Appearance:Off-white solid, Synonyms: (5-Difluoro-4-hydroxyphenyl)amino]-7,8-dihydro-5,7-dimethyl-8-(3-methylbutyl)-6(5H)-pteridone, Size: 5 mg

SU11652 VEGFR inhibitor 1 mg. SU11652 VEGFR inhibitor, Formula: C22H27ClN4O2, MW: 414.9, Cas No: 326914-10-7, Purity: /= 98%, Appearance:Orange solid, Synonyms: 5-[5-Chloro-2-oxo-1,2-dihydroindol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, Size: 1 mg

Eicosapentaenoyl ethanolamide 25 mg. Eicosapentaenoyl ethanolamide C22H35NO2, Molecular Weight: 345.5, Cas No: 109001-03-8, Purity: greater than or equal to 98%, Appearance: Pale amber oil, Solubility: Soluble in DMSO, Synonyms: EPEA, Application:, Storage: -20 deg C, Size: 25 mg

Triacetyl resveratrolSIRT activator 10 mg. Triacetyl resveratrolSIRT activator C20H28O6, Molecular Weight: 354.4, Cas No: 42206-94-0, Purity: greater than or equal to 98%, Appearance: White solid, Solubility: Soluble in DMSO, Storage: -20 deg C, Size: 10 mg

Diphtheria toxin (Corynebacterium diphtheriae) 1 mg. Diphtheria toxin (Corynebacterium diphtheriae), Source: From Corynebacterium diphtheriae, Concentration: 1ug/ul, GTP hydrolysis-dependent translocation reaction that is responsible for the movement of the ribosome along mRNA, Size: 1 mg

GW9508High potency synthetic agonist at GPR40 10 mg. GW9508High potency synthetic agonist at GPR40 C22H21NO3, Molecular Weight: 347.4, Cas No: 885101-89-3, Purity: /= 98%, Appearance: Off-white solid, Synonyms: 4-[[(3-Phenoxyphenyl)methyl]amino]benzene propanoic acid, Size: 10 mg

GW9508 High potency synthetic agonist at GPR40 50 mg. GW9508High potency synthetic agonist at GPR40C22H21NO3, MW: 347.4, Cas No: 885101-89-3, Purity: /= 98%, Appearance: Off-white solid, Synonyms: 4-[[(3-Phenoxyphenyl)methyl]amino]benzene propanoic acid, Storage: -20 deg C, Size: 50 mg

Ro 41-5253Retinoic acid receptor ligand 5 mg. Ro 41-5253Retinoic acid receptor ligand C28H36O5S, Molecular Weight: 484.7, Cas No: 144092-31-9, Purity: /= 98%, Appearance: White solid, Solubility: Soluble in DMSO, Counteracts the effects of retinoic acid on HL-60, Storage: -20 deg C, Size: 5 mg

Ro 41-5253Retinoic acid receptor ligand 25 mg. Ro 41-5253Retinoic acid receptor ligand C28H36O5S, Molecular Weight: 484.7, Cas No: 144092-31-9, Purity: /= 98%, Appearance: White solid, Solubility: Soluble in DMSO, Counteracts the effects of retinoic acid on HL-60, Storage: -20 deg C, Size: 25 mg

Zebularine DNA methylation competitiveinhibitor 10 mg. Zebularine DNA methylation inhibitor C9H12N2O5, Molecular Weight: 228.2, Cas No: 654065, Purity: /= 98%, Appearance: Off-white solid, Synonyms: 1-(B-D-Ribofuranosyl)-1,2-dihydropyrimidin-2-one, 2-Pyrimidone-1, Storage: -20 deg C, Size: 10 mg

BML-281 HDAC6 inhibitor 1mg. BML-281 HDAC6 inhibitor proliferation pancreatic cancer cell lines, C22H30N4O6, Molecular Weight: 446.5, Cas No: 1045792-66-2, Purity: /= 98%, Appearance: Off-white solid, Synonyms: N-Hydroxy-7-[5-(4-tertbutoxycarbonylaminophenyl)-3-isoxazolecarboxamido], Size: 1mg

N-Palmitoyl phosphatidylethanolamine 5 mg. N-Palmitoyl phosphatidylethanolamine, Formula: C53H104NO9P, MW: 930.4, CAS: 108321-22-8, Purity: /= 98% (TLC), Appearance: White solid, Synonyms: C16:0 NAPE, NPPE, significantly reduced food intake in a dose-dependent, Storage: -20 deg C, Size: 5 mg

OMNIMMP RED fluorogenic substrate inhibitor 100 ug. OMNIMMP RED fluorogenic substrate inhibitor, Long emission wavelength reduces, Molecular Weight: 1910.7, Purity: greater than or equal to 90%, Appearance:Lyophilized purple solid, Solubility: Soluble in DMSO, Storage: -20 deg C, Size: 100 ug

MMP-3 fluorogenic substrate inhibitor 100 ug. MMP-3 fluorogenic substrate inhibitor, Molecular Weight: 2156.9, Purity: greater than or equal to 90%, Appearance:Lyophilized orange or red solid, Solubility: Soluble in DMSO, Storage: -20 deg C, Size: 100 ug

BML-288 PDE2 inhibitor 25 mg. BML-288 PDE2 inhibitor, Formula: C14H10N4O3S, MW: 314.3, Purity: /= 98% (TLC), Appearance: Off-white solid, Storage: -20 deg C, Synonyms: 5-Methyl-6-oxo-N-(1,3,4-thiadiazol-2-yl)-7H-furo[2,3-f]indole-7-carboxamide, no significant level of binding, Size: 25 mg

Prostaglandin F2A Prostanoid receptor ligand 2 mg. Prostaglandin F2A Prostanoid receptor ligand, Formula: C20H34O5, MW: 354.5, CAS: 551-11-1, Purity: /= 99% (TLC),n uterine luteolytic prostaglandin, Synonyms: Dinoprost, 9A,11A,15S-Trihydroxy-prosta-5Z,13E-dien-1-oic acid, PGF2A, Size: 2 mg

Castanospermine Glucosidase inhibitor 100mg. Castanospermine Glucosidase inhibitor, Formula: C8H15NO4, MW: 189.2, CAS: 79831-76-8, Purity: /= 95%, Appearance: White to off-white crystalline solid, Long Term Storage: +4 deg C, Plant alkaloid, Potent inhibitor of A- and B-glucosidases, Size: 100mg

IDE-2 Induces stem cell differentiation 1mg. IDE-2 Induces stem cell differentiation C12H20N2O3, Molecular Weight: 240.3, Cas No: 1136466-93-7, Purity: /= 98%, Appearance: White solid, Solubility: Soluble in DMSO, Synonyms: 7-(2-Cyclopentylidenehydrazinyl)-7-oxoheptanoic acid, Size: 1mg

Ubiquitin activating kit 20 tests. Ubiquitin activating kit, Contains: 20X Ubiquitin Activating Enzyme Solution, Ubiquitin Solution, Ubiquitin Antibody Solution, Ubiquitin protein conjugates rabbit PAb, 20X Mg-ATP Solution, 2X Non-reducing Gel Loading Buffer, 10X Ubiquitinylation, Size: 20 tests

XAV939 PARP5a inhibitor 5 mg. XAV939 PARP5a inhibitor C14H11F3N2OS, Molecular Weight: 312.3, Cas No: 284028-89-3, Purity: greater than or equal to 98%, Appearance: White solid, Synonyms: 3,5,7,8-Tetrahydro-2-[4-(trifluoromethyl)phenyl]-4H-thiopyrano[4,3-d]pyrimidin-4-one, Size: 5 mg

XAV939 PARP5a inhibitor 25 mg. XAV939 PARP5a inhibitor C14H11F3N2OS, Molecular Weight: 312.3, Cas No: 284028-89-3, Purity: greater than or equal to 98%, Appearance: White solid, Synonyms: 3,5,7,8-Tetrahydro-2-[4-(trifluoromethyl)phenyl]-4H-thiopyrano[4,3-d]pyrimidin-4-one, Size: 25 mg

TLRgrade LPS from Salmonella minnesota R595 (Re) Ready-to-Use 1ml. TLRgrade LPS from Salmonella minnesota R595 (Re)Ready-to-Use, TLR4 activator, Concentration: 1mg/ml, Form: Liquid. Sterile, in pyrogen-free double H20, Synonyms: Lipopolysaccharide from Salmonella minnesota R595 (Re), Size: 1ml

TLRgrade LPS from Salmonella abortus equi S-form (TLRgrade) Ready-to-Use 1ml. TLRgrade LPS from Salmonella abortus equi S-form (TLRgrade)Ready-to-Use, TLR4 activator, Concentration: 1mg/ml, Form: Liquid. Sterile, Synonyms: Lipopolysaccharide from Salmonella abortus equi S-form, Size: 1ml

TLRgrade LPS from E.Coli 1ml. TLRgrade LPS from E.ColiReady-to-Use, TLR4 activator, Source: Rough (R)-form LPS isolated and purified from E. Coli EH100 (Ra-mutant), Concentration: 1mg/ml, Appearance: Clear colorless liquid, Synonyms: Lipopolysaccharide from E. Coli, Serotype EH100(Ra), Size: 1ml

TLRgrade LPS from Salmonella typhimurium S-form (TLRgrade) Ready-to-Use 1ml. TLRgrade LPS from Salmonella typhimurium S-form (TLRgrade)Ready-to-Use, TLR4 activator, Concentration: 1mg/ml, Form: Liquid, Sterile, Synonyms: Lipopolysaccharide from Salmonella typhimurium S-form, Size: 1ml

TLRgrade LPS from E.Coli Ready-to-Use 1ml. TLRgrade LPS from E.ColiReady-to-Use, TLR4 activator, Concentration: 1mg/ml, Form: Liquid, Sterile, solution in pyrogen-free double H20, Synonyms: Lipopolysaccharide from E. Coli, Serotype O55:B5 S-form, Size: 1ml

TLRgrade Lipid A from E.Coli Ready-to-Use 1ml. TLRgrade Lipid A from E.ColiReady-to-Use, TLR4 activator, Serotype R515 (Re), Concentration: 1mg/ml, Purity: /= 99.9%, Formulation: Liquid. Sterile, ready-to-use solution in pyrogen-free double distilled water, Storage: -20 deg C, Size: 1ml

TLRgrade Monophosphoryl Lipid A from Salmonella minnesota R595 (Re) Ready-to-Use 500 ul. TLRgrade Monophosphoryl Lipid A from Salmonella minnesota R595 (Re)Ready-to-Use, Purity: greater than or equal to 99.9%, Synonyms: MPL-A from Salmonella minnesota R595 (Re), Storage: -20 deg C, Size: 500 ul

TLRgrade Monophosphoryl Lipid A from E.Coli Ready-to-Use 500 ul. TLRgrade Monophosphoryl Lipid A from E.ColiReady-to-Use, TLR4 activator, Serotype R515 (Re), Purity: greater than or equal to 99.9%, Synonyms: MPL-A from E. Coli, Serotype R515 (Re), Storage: -20 deg C, Size: 500 ul

Ready-to-Use Monophosphoryl Lipid A (synthetic)TLR4 activator 100 ug. Ready-to-Use Monophosphoryl Lipid A (synthetic) TLR4 activator, Formula: C96H184N3O22P, Molecular Weight: 1763.47, Cas No: 1246298-63-4, Synonyms: MPL-A, Glucopyranosyl lipid adjuvant, GLA, Size: 100 ug

TLRgrade ODN 1668 100 ug. TLRgrade ODN 1668, Source: Synthetic, CpG oligodeoxynucleotide (Type B)-with phosphorothioate backbone. Specific ligand for mouse TLR9 (Toll-like receptor 9), Molecular Weight: 6383 (ammonium salt) Formulation: Lyophilized, Sterile, Size: 100 ug

SCREEN-WELL Ion Channel ligand library 100 ul/well. SCREEN-WELL Ion Channel ligand library, Concentration: 10mM in DMSO, contains 70 ion channel blockers and openers for use in characterizing and identifying ion channels in individual cells, Application: HTS, Storage: -80 deg C, Size: 100 ul/well

SCREEN-WELL Neurotransmitter library 100 ul/well. SCREEN-WELL Neurotransmitter library, Ideal for screening or identifying recombinant orphan G protein-coupled receptors, target validation, secondary screening, Application: HTS, Storage: -80 deg C, Size: 100 ul/well

SCREEN-WELL Adrenergic ligand library 100 ul/well. SCREEN-WELL Adrenergic ligand library, contains 83 ligands including endogenous neurotransmitters, agonists, antagonists, and marketed drugs, ideal for screening, Application: HTS, Storage: -80 deg C, Size: 100 ul/well

CCT036477Disrupts Wnt signaling 5 mg. CCT036477Disrupts Wnt signaling C21H18ClN3, Molecular Weight: 347.8, Cas No: 305372-78-5, Purity: /= 98%, Appearance: Yellow solid, Solubility: Soluble in DMSO, Synonyms: N-((4-Chlorophenyl)(2-methyl-1H-indol-3-yl)methyl)pyridin-2-amine, Size: 5 mg

CCT036477 Disrupts Wnt signaling 25 mg. CCT036477 Disrupts Wnt signaling C21H18ClN3, Molecular Weight: 347.8, Cas No: 305372-78-5, Purity: /= 98%, Appearance: Yellow solid, Solubility: Soluble in water, Synonyms: N-((4-Chlorophenyl)(2-methyl-1H-indol-3-yl)methyl)pyridin-2-amine, Size: 25 mg

IQ-1 Disrupts Wnt signaling 5 mg. IQ-1 Disrupts Wnt signaling Disrupts Wnt signalingC21H22N4O2, Molecular Weight: 362.4, Cas No: 331001-62-8, Purity: /= 98%, Synonyms: 2-(4-Acetylphenylazo)-2-(3,3-dimethyl-3,4-dihydro-2H-isoquinolin-1-ylidene)-acetamide, Storage: -20 deg C, Size: 5 mg

IQ-1 Disrupts Wnt signaling 25 mg. IQ-1 Disrupts Wnt signaling C21H22N4O2, Molecular Weight: 362.4, Cas No: 331001-62-8, Purity: /= 98%, Appearance: Orange solid, Synonyms: 2-(4-Acetylphenylazo)-2-(3,3-dimethyl-3,4-dihydro-2H-isoquinolin-1-ylidene)-acetamide, Storage: -20 deg C, Size: 25 mg

QS11 Wnt pathway activator 5 mg. QS11 Wnt pathway activator C35H33N5O2, Molecular Weight: 567.7, Cas No: 944328-88-5, Purity: /= 98%, Appearance: White solid, Synonyms: (2S)-2-[2-(Indan-5-yloxy)-9-(1,1'-biphenyl-4-ylmethyl)-9H-purin-6-ylamino]-3-phenyl-propan-1-ol, Storage: -20 deg C, Size: 5 mg

QS11 Wnt pathway activator 25 mg. QS11 Wnt pathway activator C35H33N5O2, Molecular Weight: 567.7, Cas No: 944328-88-5, Purity: /= 98%, Appearance: White solid, Synonyms: (2S)-2-[2-(Indan-5-yloxy)-9-(1,1'-biphenyl-4-ylmethyl)-9H-purin-6-ylamino]-3-phenyl-propan-1-ol, Size: 25 mg

IIIC 3DKK1 inhibitor inhibitor 500 mg. IIIC 3DKK1 inhibitor inhibitorC15H13ClN2O5, Molecular Weight: 336.73, Cas No: 1562-85-2, Purity: greater than or equal to 98%, Appearance:Very dark green to black fine crystalline powder, Solubility: Soluble in DMSO, Synonyms: Gallocyanine, Size: 500 mg

IGF-I Recombinant Protein 100 ug. IGF-I Recombinant Protein, insulin like effects, Source: Produced in E.coli, Purity: /= 98% (SDS-PAGE; RP-HPLC), Molecular Weight: 8kDa, Synonyms: Insulin-like growth factor I, Application: Western blot, Formulation: Lyophilized, Storage:-20 deg C, Size: 100 ug

PHC-SKKKK. 3 TFA 1 mg. PHC-SKKKK. 3 TFA, Formula: C82H158N10O13S. 3 CF3COOH, Molecular Weight: 1524.3. 342.1, Appearance: Colorless powder, Synonyms: PHCSK4. 3 TFA, N-palmitoyl-S-(1,2-bishexadecyloxy-carbonyl)-ethyl-(R)-cysteinyl-seryl-(lysyl)3-lysine. 3 CF3COOH, Size: 1 mg

Pro-IL-33 Recombinant Protein 10 ug. Pro-IL-33 Recombinant Protein, Source: Produced in E.coli, Purity: /= 95% (SDS-PAGE), MW: 30kD, Synonyms: Interleukin-33, NF-HEV, IL-1F11, Recombinant human IL-33 (aa 1-270) fused at the C-terminus to a His-tag, Application: Wb, Storage:-20 deg C, Size: 10 ug

DLK1 (human) (His-tag) Notch ligand Recombinant protein 10ug. DLK1 (human) (His-tag) Notch ligand Recombinant protein, Source: Produced by HEK 293 cells, Purity: /= 95%, Formulation: Lyophilized, Synonyms: Fetal antigen 1, Protein delta homolog 1, Preadipocyte factor 1, Pref-1, FA1, pG2, Size: 10ug

IL-6 Recombinant Protein 20 ug. IL-6 Recombinant Protein, Source: Produced in E.coli, Purity: /= 95%, MW: 21kDa, Appearance: White lyophilized (freeze-dried) powder, Synonyms: Interleukin-6, IFN-B2, B-cell differentiation factor, BSF-2, Form: Lyophilized, Storage: -20 deg C, Size: 20 ug

IL-6 Recombinant Protein 10ug. IL-6 Recombinant Protein, Source: Produced in E.coli, Purity: /= 95%, MW: 21.7kDa, Appearance: White lyophilized (freeze-dried) powder, Synonyms: Interleukin-6, IFN-B2, B-cell differentiation factor, BSF-2, Form: Lyophilized, Storage: -20 deg C, Size: 10ug

IL-3 Recombinant Protein 10 ug. IL-3 Recombinant Protein, Source: Produced in E.coli, Purity: /= 95%, MW: 15kDa, Appearance: White lyophilized (freeze-dried) powder, Synonyms: Interleukin-6, IFN-B2, B-cell differentiation factor, BSF-2, Form: Lyophilized, Storage: -20 deg C, Size: 10 ug

IL-3 Recombinant Protein 10ug. IL-3 Recombinant Protein, Source: Produced in E.coli, Purity: /= 97%, MW: 15.1kDa, Appearance: White lyophilized (freeze-dried) powder, Synonyms: Interleukin-6, IFN-B2, B-cell differentiation factor, BSF-2, Form: Lyophilized, Storage: -20 deg C, Size: 10ug

TLRgrade LPS from E.Coli Ready-to-Use 1ml. TLRgrade LPS from E.ColiReady-to-Use, TLR4 activator, Concentration: 1mg/ml, Form: Liquid. Sterile, ready-to-use solution in pyrogen-free double distilled water, Synonyms: Lipopolysaccharide from E. Coli, Serotype R515 (Re), Size: 1ml

ODN 1826 (TLRgrade) (synthetic)TLR9 ligand 100 ug. ODN 1826 (TLRgrade) (synthetic)TLR9 ligand, with phosphorothioate backbone, Molecular Weight: 6383 (ammonium salt), Synonyms: CpG-B Sequence: 5'-tccatgacgttcctgacgtt-3' ( phosphorothioate linkage), Storage: -20 deg C, Size: 100 ug

TLRgrade ODN 1585 100ug. TLRgrade ODN 1585, Source: Synthetic, CpG oligodeoxynucleotide (Type A) optimized for NK cell activation with mixed phosphodiester/phosphorothioate backbone. Specific ligand for mouse TLR9, MW: 6643 (ammonium salt) Formulation: Lyophilized, Sterile, Size: 100ug

TLRgrade ODN 1585 1 mg. TLRgrade ODN 1585, Source: Synthetic, optimized for NK cell activation with mixed phosphodiester/phosphorothioate backbone, Molecular Weight: 6643 (ammonium salt) Formulation: Lyophilized, Sterile, Endotoxin Content: 0.002EU/ug (LAL test; BioWhittaker), Size: 1 mg

TLRgrade ODN M362 1 mg. TLRgrade ODN M362, Source: Synthetic, CpG oligodeoxynucleotide (Type C) with phosphorothioate backbone. Specific ligand for TLR9 (Toll-like receptor 9, Molecular Weight: 8073 (ammonium salt) Formulation: Lyophilized, Sterile, Size: 1 mg

TLRgrade ODN 2395 1 mg. TLRgrade ODN 2395, Source: Synthetic, CpG oligodeoxynucleotide (Type C) with phosphorothioate backbone. Specific ligand for human and mouse TLR9, Molecular Weight: 7068 (ammonium salt) Formulation: Lyophilized, Sterile, Size: 1 mg

TLRgrade ODN 2118 100 ug. TLRgrade ODN 2118, Source: Synthetic( Control), Molecular Weight: 6643 (ammonium salt), '-ggGGTCAAGCTTGAgggggg-3'(lower case letters indicate phosphorothioate linkage), Avoids the isolation of multiple identical clones, Formulation: Lyophilized, Sterile, Size: 100 ug

SCREEN-WELL Dopaminergic ligand library 100 ul/well. SCREEN-WELL Dopaminergic ligand library, contains 80 ligands including endogenous neurotransmitters, agonists, antagonists, and marketed drugs. The library is ideal for screening, Application: HTS, Storage: -80 deg C, Size: 100 ul/well

SCREEN-WELL Serotonergic ligand library 100 ul/well. SCREEN-WELL Serotonergic ligand library, Contains 79 ligands including endogenous neurotransmitters, agonists, antagonists, and marketed drugs. The libraryis ideal for screening, Application: HTS, Storage: -80 deg C, Size: 100 ul/well

SCREEN-WELL Opioid ligand library 100 ul/well. SCREEN-WELL Opioid ligand library, 74 ligands including endogenous neurotransmitters, agonists, antagonists, and marketed drugs, ideal for screening or identifying recombinant orphan, Application: HTS, Storage: -80 deg C, Size: 100 ul/well

SCREEN-WELL Cholinergic ligand library 100 ul/well. SCREEN-WELL Cholinergic ligand library, contains 67 compounds ligands including endogenous neurotransmitters, agonists, antagonists, and marketed drugs, Application: HTS, Storage: -80 deg C, Size: 100 ul/well

SCREEN-WELL Histaminergic ligand library 100 ul/well. SCREEN-WELL Histaminergic ligand library, contains 41 ligands including endogenous neurotransmitters, agonists, antagonists, and marketed drugs, library is ideal for screening, Application: HTS, Storage: -80 deg C, Size: 100 ul/well

SCREEN-WELL Ionotropic Glutamatergic ligand library 100 ul/well. SCREEN-WELL Ionotropic Glutamatergic ligand library, contains 60 ligands including endogenous neurotransmitters, agonists, antagonists, and marketed drugs, Application: HTS, Storage: -80 deg C, Size: 100 ul/well

SCREEN-WELL Metabotropic Glutamatergic ligand library 100ul/well. SCREEN-WELL Metabotropic Glutamatergic ligand library, contains 49 ligands including endogenous neurotransmitters, antagonists, and marketed drugs, library is ideal for screening, Apps: HTS, Storage: -80 deg C, Size: 100ul/well

SCREEN-WELL GABAergic ligand library 100 ul/well. SCREEN-WELL GABAergic ligand library, contains 56 ligands including endogenous neurotransmitters, agonists, antagonists, and marketed drugs, library is ideal for screening, Application: HTS, Storage: -80 deg C, Size: 100 ul/well

SCREEN-WELL Purinergic ligand library 100 ul/well. SCREEN-WELL Purinergic ligand library, contains 72 CNS receptor ligands including endogenous neurotransmitters, agonists, antagonists, and marketed drugsThe library is ideal for screening, Application: HTS, Storage: -80 deg C, Size: 100 ul/well

Screen-well epigenetics library 100ul/well. Screen-well epigenetics library, Contains: 43 compounds supplied in DMSO at a concentration of 10mM, contains inhibitors of these important enzymes: HDACs, SIRTs, Lysine demethylases, HATs, Histone, Application: HTS, Storage: -80 deg C, Size: 100ul/well

SCREEN-WELL Epigenetics library 500 ul/well. SCREEN-WELL Epigenetics library, Contains: 43 compounds supplied in DMSO at a concentration of 10mM, contains 43 compounds with defined activity against enzymes epigenetic modification of lysine, Application: HTS, Storage: -80 deg C, Size: 500 ul/well

SCREEN-WELL Wnt Pathway library 100 ul/well. SCREEN-WELL Wnt Pathway library, Concentration: DMSO solutions (10mM), Contains: 71 compounds with defined and diverse Wnt pathway activity, mechanistically different compound classes are included, Application: HTS, Storage: -80 deg C, Size: 100 ul/well

SCREEN-WELL Wnt Pathway library 500 ul/well. SCREEN-WELL Wnt Pathway library, Concentration: DMSO solutions (10mM), Contains: 71 compounds with defined and diverse Wnt pathway activity, mechanistically different compound classes are included, Application: HTS, Storage: -80 deg C, Size: 500 ul/well

SCREEN-WELL FDA approved drug library 100 ul/well. SCREEN-WELL FDA approved drug library, Concentration: 10 mM in DMSO, Contains: Over 770 compounds, selected to maximize chemical and pharmacological diversity, Accelerates drug optimization, Application: HTS, Storage: -80 deg C, Size: 100 ul/well

SCREEN-WELL Natural Product library 500 ul/well. SCREEN-WELL Natural Product library, Concentration: 2mg/ml in DMSO, Contains: 502 compounds including compounds from the following classes of products: Terpenoids, Peptolides, Flavones, Coumarins, Alkaloids, Application: HTS, Size: 500 ul/well

SCREEN-WELL Natural Product library 100 ul/well. SCREEN-WELL Natural Product library, Concentration: 2mg/ml in DMSO, Contains: 502 compounds including compounds from the following classes of products: Terpenoids, Peptolides, Flavones, Coumarins, Alkaloids, Application: HTS, Size: 100 ul/well

DaptomycinLipopeptide antibiotic 20mg. DaptomycinLipopeptide antibiotic, Formula: C72H101N17O26, Molecular Weight: 1620.7, Cas No: 103060-53-3, Purity: /= 93%, Appearance: Off-white to pale yellow crytalline powder, Solubility: Soluble in water (25mg/ml), Synonyms: Cubicin, LY146032, Size: 20mg

Daptomycin Lipopeptide antibiotic 100 mg. Daptomycin Lipopeptide antibiotic, Formula: C72H101N17O26, Molecular Weight: 1620.7, Cas No: 103060-53-3, Purity: /= 93%, Appearance: Off-white to pale yellow crytalline powder, Solubility: Soluble in water, Synonyms: Cubicin, LY146032, Size: 100 mg

Rapamycin Immunosuppressant 25 mg. Rapamycin Immunosuppressant, Formula: C51H79NO13, Molecular Weight: 914.2, Cas No: 53123-88-9 MI: 14: 8114 RTECS: VE6250000, Purity: /= 98%, Appearance: Off-white or yellow solid, Synonyms: Sirolimus, AY-22,989, RAPA, Rapamune, Storage: -20 deg C, Size: 25 mg

Matrix metalloproteinase-19 (MMP-19) fluorometric drug discovery kit 96 wells. Matrix metalloproteinase-19 (MMP-19) fluorometric drug discovery kit, Synonyms: RASI, Contains: 1 vial MMP-19 enzyme, 1 vial Substrate, 1 vial 6'-TAMRA calibration standard, assay buffer, control inhibitor, Size: 96 well

Category